MPI Research announced today that William M. Harrison, B.S., was promoted to President and Chief Operating Officer, and James G. Laveglia, Ph.D., was promoted to Executive Vice President and Director of Research on December 20, 2001 at the Board of Directors meeting. Both, Bill and Jim, continue to serve as members of the Board of Directors of MPI Research.

William U. Parfet, MBA, Chairman and CEO, commented, “Bill and Jim are committed to holding the helm of this rapid growing company. We have partnered their abilities to structure and manage our capability, facility, and staffing enhancements, and new technological approaches as the company grows. These men are dedicated to the success of MPI Research, and their accomplishments and leadership have been critical factors of our success and will guide our future.”

MPI Research exists to provide non-clinical research that meets the requirements of pharmaceutical, animal health and chemical companies as well as governmental agencies, as they develop products for a healthier world. MPI employees specialize in a wide variety of scientific disciplines including toxicology, pharmacology, metabolism, pathology, clinical pathology, reproductive and developmental biology, veterinary science, neuroscience, analytical chemistry, computer science, regulatory science, and statistics.

Home | News